NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 195 filers reported holding NEVRO CORP in Q3 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $9,060,000 | -31.5% | 86,799 | -51.6% | 3.92% | +14.7% |
| Q2 2016 | $13,230,000 | -12.6% | 179,370 | -33.3% | 3.42% | +18.3% |
| Q1 2016 | $15,140,000 | -30.3% | 269,108 | -16.4% | 2.89% | -5.1% |
| Q4 2015 | $21,725,000 | +73.4% | 321,815 | +19.2% | 3.04% | +82.8% |
| Q3 2015 | $12,528,000 | -24.6% | 270,063 | -12.7% | 1.67% | +4.3% |
| Q2 2015 | $16,620,000 | +83.0% | 309,217 | +63.1% | 1.60% | +97.6% |
| Q1 2015 | $9,084,000 | – | 189,543 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |